Standard Chemical & Pharmaceutical Statistics
Total Valuation
Standard Chemical & Pharmaceutical has a market cap or net worth of TWD 10.88 billion. The enterprise value is 12.89 billion.
Market Cap | 10.88B |
Enterprise Value | 12.89B |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
Earnings Date | Feb 27, 2025 |
Ex-Dividend Date | Aug 1, 2024 |
Share Statistics
Standard Chemical & Pharmaceutical has 178.70 million shares outstanding. The number of shares has decreased by -0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 178.70M |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 47.51% |
Owned by Institutions (%) | 6.13% |
Float | 82.35M |
Valuation Ratios
The trailing PE ratio is 12.85.
PE Ratio | 12.85 |
Forward PE | n/a |
PS Ratio | 1.62 |
PB Ratio | 1.84 |
P/TBV Ratio | 1.91 |
P/FCF Ratio | 10.05 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.32, with an EV/FCF ratio of 11.90.
EV / Earnings | 15.21 |
EV / Sales | 1.92 |
EV / EBITDA | 7.32 |
EV / EBIT | 9.40 |
EV / FCF | 11.90 |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.09.
Current Ratio | 2.90 |
Quick Ratio | 1.85 |
Debt / Equity | 0.09 |
Debt / EBITDA | 0.44 |
Debt / FCF | 0.71 |
Interest Coverage | 71.91 |
Financial Efficiency
Return on equity (ROE) is 14.54% and return on invested capital (ROIC) is 8.99%.
Return on Equity (ROE) | 14.54% |
Return on Assets (ROA) | 7.73% |
Return on Capital (ROIC) | 8.99% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.61 |
Inventory Turnover | 2.39 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.94% in the last 52 weeks. The beta is 0.13, so Standard Chemical & Pharmaceutical's price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | -3.94% |
50-Day Moving Average | 62.69 |
200-Day Moving Average | 66.35 |
Relative Strength Index (RSI) | 39.52 |
Average Volume (20 Days) | 180,979 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Standard Chemical & Pharmaceutical had revenue of TWD 6.71 billion and earned 847.58 million in profits. Earnings per share was 4.74.
Revenue | 6.71B |
Gross Profit | 2.94B |
Operating Income | 1.37B |
Pretax Income | 1.53B |
Net Income | 847.58M |
EBITDA | 1.73B |
EBIT | 1.37B |
Earnings Per Share (EPS) | 4.74 |
Balance Sheet
The company has 1.73 billion in cash and 766.40 million in debt, giving a net cash position of 966.59 million or 5.41 per share.
Cash & Cash Equivalents | 1.73B |
Total Debt | 766.40M |
Net Cash | 966.59M |
Net Cash Per Share | 5.41 |
Equity (Book Value) | 8.88B |
Book Value Per Share | 33.05 |
Working Capital | 3.20B |
Cash Flow
In the last 12 months, operating cash flow was 1.58 billion and capital expenditures -497.55 million, giving a free cash flow of 1.08 billion.
Operating Cash Flow | 1.58B |
Capital Expenditures | -497.55M |
Free Cash Flow | 1.08B |
FCF Per Share | 6.06 |
Margins
Gross margin is 43.81%, with operating and profit margins of 20.39% and 12.63%.
Gross Margin | 43.81% |
Operating Margin | 20.39% |
Pretax Margin | 22.80% |
Profit Margin | 12.63% |
EBITDA Margin | 25.81% |
EBIT Margin | 20.39% |
FCF Margin | 16.14% |
Dividends & Yields
This stock pays an annual dividend of 2.70, which amounts to a dividend yield of 4.43%.
Dividend Per Share | 2.70 |
Dividend Yield | 4.43% |
Dividend Growth (YoY) | 8.00% |
Years of Dividend Growth | 1 |
Payout Ratio | 56.92% |
Buyback Yield | 0.01% |
Shareholder Yield | 4.44% |
Earnings Yield | 7.78% |
FCF Yield | 9.95% |
Stock Splits
The last stock split was on August 19, 2011. It was a forward split with a ratio of 1.07.
Last Split Date | Aug 19, 2011 |
Split Type | Forward |
Split Ratio | 1.07 |
Scores
Standard Chemical & Pharmaceutical has an Altman Z-Score of 4.91.
Altman Z-Score | 4.91 |
Piotroski F-Score | n/a |